Ledger.Open graph →
SEC Form D · filed June 12, 2023

Revere Pharmaceuticals Inc

Offering
$3.6M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ARLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ian R. Silverman · Arlington, MAExec · DirectorMarc R. Lippman · Arlington, MADirectorKollol R. Pal · Arlington, MADirectorJedd R. Levine · Arlington, MAExec · DirectorJames W. Mccollum · Coronado, CAExec · DirectorMichael J. Weinbaum · Stamford, CTDirectorGeneral Partner of the General Partner 83North FXV Manager, Ltd · Herzliya, L3Exec · DirectorGerald W. Horn · Deerfield, ILDirectorJason K. Giordano · Hanover, PAExec · DirectorJohan H. Aspen · Stockholm, V7Exec · DirectorMarc Sharinn · LAKE SUCCESS, NYDirectorChas Bountra · LONDON, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗